|
Volumn 23, Issue 10, 2014, Pages 705-709
|
Psoriasis: To treat or to manage?
|
Author keywords
Biologics; Comorbidity; Management; Psoriasis; Treatment
|
Indexed keywords
BIOLOGICAL PRODUCT;
ANTIIDIOTYPIC ANTIBODY;
IMMUNOSUPPRESSIVE AGENT;
METHOTREXATE;
ARTICLE;
BARIATRIC SURGERY;
BIOLOGICAL THERAPY;
BODY SURFACE;
COMORBIDITY;
DERMATOLOGY LIFE QUALITY INDEX;
DISEASE CONTROL;
DISEASE SEVERITY;
HUMAN;
PSORIASIS;
PSORIASIS AREA AND SEVERITY INDEX;
QUALITY CONTROL;
QUALITY OF LIFE;
SMOKING;
SMOKING CESSATION PROGRAM;
SYSTEMIC THERAPY;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ULTRAVIOLET RADIATION;
WEIGHT REDUCTION;
BIOSYNTHESIS;
IMMUNOLOGY;
OBESITY;
RISK FACTOR;
ANTIBODIES, ANTI-IDIOTYPIC;
BIOLOGICAL PRODUCTS;
COMORBIDITY;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
METHOTREXATE;
OBESITY;
PSORIASIS;
RISK FACTORS;
TREATMENT OUTCOME;
|
EID: 84907867910
PISSN: 09066705
EISSN: 16000625
Source Type: Journal
DOI: 10.1111/exd.12437 Document Type: Article |
Times cited : (66)
|
References (61)
|